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Emilie Bastard, MD,* Sebastien Ansaldi, MD,* Frederic Franceschi, MD,*
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Laurence Tafanelli, MD,* Jean-François Avierinos, MD,* Didier Raoult, MD, PHD,†
Jean-Claude Deharo, MD,* Gilbert Habib, MD*
Marseille, France
O B J E C T I V E S We sought to determine the incidence, diagnostic value, and outcome of intracar-
diac masses observed by echocardiography after device removal. We hypothesized that these “ghosts”
of leads could be associated with the diagnosis of cardiac device–related infective endocarditis (CDRIE).
B A C KG ROUND The echocardiographic appearance of residual ﬂoating masses in the right atrium
after removal of permanent pacemakers and implantable cardioverter-deﬁbrillators was recently
described. However, the signiﬁcance of these ghosts and their relationship with CDRIE are unknown.
METHOD S The pre-operative clinical, microbiological, and echocardiographic conditions; the
indication; and the removal technique were analyzed in a retrospective cohort including all consecutive
patients who underwent percutaneous lead removal. Three groups were formed according to the ﬁnal
diagnosis: CDRIE, local device infection, and noninfectious indications. The incidence of ghosts was
compared among the 3 groups. All clinical, infectious, and extraction-related factors were studied for
their association with ghosts. All patients with ghosts were followed after hospitalization.
R E S U L T S Two hundred twelve patients underwent lead removal. Ghosts were observed in 17
patients (8% incidence), including 14 (16%) of 88 patients with CDRIE and 3 (5%) of 59 patients with local
device infection. Ghosts were never observed among the remaining 65 noninfected patients. A
signiﬁcant association was found between CDRIE and the presence of a ghost (odds ratio: 7.63, 95%
conﬁdence interval: 2.12 to 27.45, p  0.001). At 3 months, 2 patients with ghosts died suddenly, 2
underwent surgery, and 1 had a pulmonary embolism.
CONC L U S I O N S Ghosts are observed in 8% of patients after percutaneous device extraction. Their
presence is suggestive of device infection and seems to be associated with the diagnosis of CDRIE. The
prognostic signiﬁcance of such ﬁndings needs further investigation. (J Am Coll Cardiol Img 2010;3:
673–81) © 2010 by the American College of Cardiology Foundation
From the Departments of *Cardiology and †Infectious Disease, La Timone Hospital, Marseille, France.Manuscript received November 5, 2009; revised manuscript received December 8, 2009, accepted December 26, 2009.
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674he number of implanted intracardiac de-
vices has dramatically increased during the
past decade with the aging of the general
population and the publication of large ran-
omized trials demonstrating the beneficial impact
f cardiac resynchronization therapy and the im-
lantable cardioverter-defibrillator (ICD) on sur-
ival (1–5). Along with this trend, the number of
ead removal procedures has been growing rapidly.
he main indications for lead removal are cardiac
evice–related infective endocarditis (CDRIE), lo-
al device infection (LDI), lead dysfunction, and
evice upgrading (6). CDRIE is rare, with reported
ates ranging from 0.13% to 7% for permanent
acemakers (7,8) and from 0.7% to 1.2% for ICDs
1,9). The presence of CDRIE substantially in-
reases mortality, morbidity, and costs (10–13).
emoval of infected cardiac leads carries with it its
wn problems, mainly because of the risk of pul-
onary embolism (10,14). However, percutaneous
emoval is usually feasible, even in cases with a large
amount of vegetation (15). Moreover,
CDRIE is difficult to diagnose because of
the high rates of negative blood cultures
and negative echocardiographic findings
(10,11,16).
After implantation, a fibrotic encapsu-
lating process forms around the device
leads (17,18). That fibrous sheath in-
creases over time and becomes endotheli-
alized (19) as a way to tolerate foreign
materials in the bloodstream. However, in
he presence of lead infection, this fibrous sheath
ight be mixed with infective vegetation. Recently,
izzello et al. (20) described an echocardiographic
ase of a post–lead removal mass representing the
ersistence of the fibrous sheath covering the lead.
e recently described another case of persistent
brous sheath as the ghost of the infected lead
equiring surgical treatment (21). However, the
ncidence and clinical significance of these ghosts
ave never been studied. We sought to determine
he incidence, diagnostic value, and outcome of
ntracardiac masses observed by echocardiography
fter device extraction. We hypothesized that these
hosts of leads could be associated with the diag-
osis of CDRIE.
E T H O D S
atient population and data collection. The study
ohort consisted of all consecutive patients under-
tedoing percutaneous lead removal at the Department vf Cardiology (La Timone Hospital, Marseille,
rance) from July 2004 to July 2008. The popula-
ion was identified using several resources including
he hospital lead extraction database, endocarditis
atabase, and the computerized central diagnostic
ndex. The unique exclusion criterion was the ab-
ence of post–lead removal echocardiography dur-
ng hospitalization.
All data concerning pre-operative clinical, micro-
iological, and echocardiographic conditions; the
ndication; and the removal technique were re-
orded on the day of the procedure.
All echocardiographic examinations were per-
ormed within the week after the removal proce-
ure. Transthoracic echocardiography (TTE) was
erformed before and after lead removal in all
atients. Transesophageal echocardiography was
erformed before removal only in patients with
uspected LDI or CDRIE and after removal when
TE was not feasible because of the lack of echo-
enicity or when doubt persisted.
All patients with suspected infection had stan-
ard blood cultures and special samples for isolation
f intracellular pathogens and for various specific
ntibodies performed. Lead culture and wound
wab culture from generator-pocket tissue were
erformed in all patients and interpreted with the
linical and echocardiographic data. In cases of
nfection, the antibiotic treatment was discussed by
multidisciplinary team. The population was sep-
rated into 3 groups according to the final diagno-
is: CDRIE, LDI, and noninfective indications.
eﬁnitions. CDRIE patients were defined accord-
ng to the previous validated diagnostic criteria
10,22). However, as proposed by Sohail et al. (16),
resence of lead vegetation and clinical evidence of
DI were considered major criteria for the diagno-
is of definite CDRIE. Moreover, lead culture was
sed as a major criterion of CDRIE only in the
bsence of pocket infection or when the leads were
emoved using a remote incision from the pocket
16). Major bacteriologic criteria were defined by
lood cultures positive for typical endocardial
athogens or persistently positive for a microorgan-
sm consistent with infective endocarditis. Vegeta-
ion was defined as an oscillating intracardiac mass
n the electrode leads, cardiac valve leaflets, or
ndocardial surface in the setting of the valve,
hich was present in 1 echocardiographic plane,
nd positive blood and/or lead tip cultures. Echo-
ardiographic data included the presence and the
aximal length of vegetations. The measurement ofB B R E V I A T I O N S
N D A C R O N YM S
DRIE cardiac device–rela
nfective endocarditis
CD implantable
ardioverter-defibrillator
DI local device infection
TE transthoracicegetation length was performed on various planes,
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675nd the maximal length was used. In the presence of
ultiple vegetations, the largest length was used for
nalysis. Valvular regurgitation was assessed
emiquantitatively.
LDI was clinically defined by the presence of
ocal signs of inflammation at the generator
ocket, including erythema, warmth, fluctuance,
ound dehiscence, erosion, tenderness, and pu-
ulent drainage.
ercutaneous lead removal procedures. Percutaneous
emoval or surgery with extracorporeal circulation
as based on the judgment of the multidisciplinary
reatment team. Criteria that led to surgery with
xtracorporeal circulation, if general conditions per-
itted it, were vegetation length 20 mm, severe
ricuspid regurgitation, and associated left-sided
ndocarditis.
All percutaneous removal procedures were per-
ormed in an operating room or electrophysiology
aboratory, with the patient under general anesthe-
ia or heavy sedation, with on-site cardiothoracic
urgery support. The procedures were performed by
xperienced operators. The first step in all patient
xtracting procedures was simple traction on the
ead from the cardiac device pocket. For leads
mplanted for 6 months, simple traction was
pplied after introduction of a locking stylet. When
emoval by simple traction was unsuccessful, we
sed at least one of the following tools: laser sheath
r snare. Pacemaker-dependent patients were
quipped with an epicardial right ventricular pace-
aker in the days preceding the removal procedure
or CDRIE. Data concerning lead- and procedure-
elated factors, such as implant duration time,
umber of atrial and ventricular leads, the presence
f defibrillator or coronary sinus lead, and use of
aser sheath/lasso, were collected.
nd point. Appearance of a ghost was defined as the
rimary end point. A ghost was defined as a
ost-removal, new, tubular, mobile mass detected
y echocardiography following the lead’s intracar-
iac route in the right cavities (Figs. 1 to 3; Online
ideo 1). Post-removal lesions of subvalvular tri-
uspid apparatus were not considered ghosts.
ollow-up. All patients with ghosts were followed.
his follow-up consisted of clinical examination
nd TTE at 1 and 3 months. Further follow-up was
btained by telephone contact (patients and physi-
ians) and TTE at the end of the study. We
articularly focused on survival and embolic or
nfectious events.
tatistical analysis. All continuous variables were
xpressed as medians (minimal and maximal values)r mean  SD and compared using the nonpara-
etric Kruskal-Wallis test. Categorical variables
ere expressed as percentages and compared using
he chi-square or Fisher exact test. Odd ratios were
stimated by logistic regression. All tests of signif-
cance were 2 sided, and a p value 0.05 was
onsidered significant. Statistical analysis was per-
ormed using SPSS 15.0 (SPSS Inc., Chicago,
llinois).
Figure 1. Transesophageal Echocardiography Showing a Ghost in
(Patient #5)
In this patient, a 110° transesophageal echocardiographic view allow
good visualization of both the superior vena cava (SVC), the right a
(RA), and the left atrium (LA). A ghost presents as a post–lead remo
tubular, mobile mass following the lead’s intracardiac route in the r
ties (arrow). The long tubular mass is seen in the SVC, going into t
See Online Video 1. IVC  inferior vena cava.
Figure 2. Transthoracic Echocardiographic 5-Chamber View Sho
Ghost in the RA (Patient #16)
This standard apical view allows satisfactory visualization of the righ
ties. A large and thick tubular mass (arrow) is seen in the RA (arrow
lapsing into the right ventricle (RV). LV  left ventricle; other abbrethe SVC
s a
trium
val, new,
ight cavi-
he RA.wing a
t cavi-
), pro-
viationsas in Figure 1.
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676E S U L T S
atient characteristics. During the study period, 246
atients underwent percutaneous lead removal.
hirty-four patients were excluded because they
ould not have an echocardiographic examination at
ur institution after removal procedure (5 extrac-
ions for CDRIE, 15 for local infection, and 14 for
ther indications). Thus, the study cohort consisted
f 212 patients with a total of 456 endovascular leads
emoved. Indication for lead extraction was CDRIE
n 88 patients, LDI in 59 patients, and a noninfective
ndication in 65 patients. Baseline characteristics of
ach group of patients are summarized in Table 1.
here were 154 male patients (73%) and 58 female
atients (27%) with a median age of 72 years (range 13
o 93 years). Detailed indications for lead removal are
ummarized in Table 2. On average, 2.24 0.76 leads
ransesophageal Echocardiography Showing a Ghost in the SVC
3)
typical view of the right cavities obtained using a 97° trans-
l echocardiographic view. The probe is placed at the lower por-
esophagus, allowing visualization of a long segment of the SVC.
ular mass is clearly seen in the SVC (arrow). Abbreviation as in
Table 1. Patient Characteristics in the 3 Groups
CDRIE (n  8
Age, yrs, median (min-max) 73 (13–93)
Men, n (%) 65 (74)
LVEF 35%, n (%) 27 (31)
Number of leads, median (min-max) 2 (1–5)
Atrial leads 1 (0–2)
Ventricular leads 1 (1–3)
Time from implant, months, median (min-max) 46 (0.7–261
Patients with leads older than 1 yr, n (%) 70 (80)
Use of laser and/or snare, n (%) 42 (48)CDRIE  cardiac device–related infective endocarditis; LDI  local device infection;ere removed per patient. There were 63 ICD leads
nd 32 coronary sinus leads removed.
Of the 147 patients undergoing removal for
nfective reasons, microorganisms were found in
13 (77%). In the CDRIE group, blood cultures
ere positive in 41 patients (46%) and lead cultures
ere positive in 54 patients (51%). In the LDI
roup, leads cultures were positive in 44 patients
75%). Coagulase-negative staphylococci (33%) and
taphylococcus aureus (29%) were the most common
auses of cardiac device infection, followed by
ram-negative bacilli (9%) and Propionibacterium
cnes (8%).
Pre-operative echocardiography identified vege-
ations in 57 infected patients (39%). The median
egetation length was 10 mm (range 5 to 35 mm).
n the same pre-operative echocardiography, 8
hickened leads were observed. Post-removal trans-
sophageal echocardiography was performed in 37
atients (29 with CDRIE, 5 with LDI, and 3 for
ther indications).
Laser or snare assistance was required for 97 of
12 patients (49%). The need for snare or laser
heath increased with the age of the leads, but no
LDI (n  59)
Noninfective Indications
(n  65) p Value
76 (36–93) 67 (15–84) 0.001
42 (71) 47 (72) 0.94
18 (31) 37 (57) 0.001
2 (1–4) 2 (1–3) 0.80
1 (0–3) 1 (0–2) 0.92
1 (1–2) 1 (1–2) 0.19
69 (0.9–217) 29 (0.1–211) 0.16
46 (78) 53 (82) 0.88
31 (53) 24 (37) 0.19
Table 2. Lead Removal Indications
Cardiac device infection–related endocarditis 88 (41%)
Local device infection 59 (28%)
Noninfective indication 65 (31%)
Lead dysfunction 29 (14%)
Upgrading from a PPM to an ICD and/or CRT 26 (12%)
Device replacement 4 (2%)
Symptomatic venous occlusion 2 (1%)
Treatment of breast malignancy 2 (1%)
Heart perforation 1 (0.5%)
Phrenic stimulation 1 (0.5%)
CRT  cardiac resynchronization therapy; ICD  implantable cardioverter-
deﬁbrillator; PPM  permanent pacemaker.Figure 3. T
(Patient #1
This is an a
esophagea
tion of the
A long tub8)
)LVEF  left ventricular ejection fraction.
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677ssociation was found between the indication of
ead removal and the need for a lasso and/or laser
heath.
host identiﬁcation. Ghosts were observed in 17
atients (8% incidence), including 14 (16%) of 88
atients with CDRIE and 3 (5%) of 59 patients
ith LDI. Ghosts were never observed among the
emaining 65 noninfected patients. A significant
ssociation was found between CDRIE and the
resence of ghosts (odds ratio: 7.63, 95% confi-
ence interval: 2.12 to 27.45, p  0.001). The only
ther factor associated with ghosts was a positive
ead culture (odds ratio: 2.98, 95% confidence
nterval: 1.01 to 8.78, p  0.048). Univariate
nalysis of ghost predictors in the entire population
s shown in Table 3. The locations of the ghosts
ere the superior vena cava in 10 patients, right
entricle trabeculations in 4 patients, and the tri-
uspid valve in 3 patients. The main features of
hese 17 patients are summarized in Table 4.
utcome. Patients with a ghost were followed for a
edian period of 15 months (range 4 to 38
onths). The follow-up was complete for clinical
Table 3. Ghost Predictors in Univariate Analysis
Ghost Patie
(n  17)
Indications
CDRIE* vs. other indications (%) 14 (82)
Patient-related factors
Age, yrs, median (min-max) 71 (39–87
Sex (male/female) 14/3
LVEF 35%, n (%) 6 (35)
ICD, n (%) 7 (41)
Resynchronization therapy, n (%) 2 (12)
Previous TR (yes/no) 0/0
Thickened lead, n (%) 2 (12)
Infectious factors
Positive blood culture, n (%) 5 (29)
Positive lead culture, n (%) 12 (71)
Coagulase-negative staphylococci,* n (%) 6 (35)
Staphylococcus aureus,* n (%) 7 (41)
Others,* n (%) 3 (18)
No microorganism identiﬁed,* n (%) 1 (6)
CDRIE* with negative blood cultures,* n (%) 1 (6)
Extraction-related factors
Number of leads, median (min-max) 2 (1–4)
Auricular leads, median (min-max) 1 (1–2)
Ventricular leads, median (min-max) 1 (1–2)
Median implantation time (min-max) 46.7 (0.7–17
Leads 1 yr, n (%) 14 (82)
Use of laser sheath/lasso, n (%) 5 (29)
*Statistical analysis for infected patients (n  147).
CI  conﬁdence interval; TR  tricuspid regurgitation; other abbreviations as in Tand echocardiographic data for all the 17 patients at
months. During hospitalization, all patients re-
eived at least 1 antibiotic treatment with an aver-
ge duration of 5.4 weeks. Two patients underwent
urgery because of their ghosts. One (Patient #3)
equired surgery because of an uncontrolled infec-
ious process. The pathological examination of the
host showed inflammatory thrombi corresponding
o possible vegetation. In the second case (Patient
12), the ghost extended from the right to the left
trium through a patent foramen ovale and was
emoved surgically because of the high risk of
ystemic embolism (21).
A ghost persisted in 8 patients at 1 month and in
patients at 3 months. During the follow-up, 3
atients died, 2 (Patients #1 and #17) suddenly at
ays 19 and 90 and 1 (Patient #2) of severe cardiac
eart failure at 12 months. A ghost was still present
n the last TTE in the 3 patients who died. The
ain characteristics of these patients are summarized
n Table 5. Another patient (Patient #10) under-
ent heart transplantation because of terminal heart
ailure 5 months after extraction. One patient (Pa-
Other Patients
(n  195) p Value
Odds Ratio
(95% CI)
74 (38) 0.001 7.63 (2.12–27.45)
72 (13–96) 0.78
140/55 0.41
76 (39) 0.77
56 (29) 0.28
30 (15) 1.00
3/2 1.00
6 (3) 0.13
31 (16) 0.18
87 (45) 0.04 2.98 (1.01–8.78)
36 (28)
30 (23)
31 (22) 0.16
33 (25)
15 (12) 0.70
2 (1–5) 0.22
1 (0–3) 0.48
1 (1–3) 0.17
45.7 (0.1–240) 0.91
155 (80) 1.00
92 (47) 0.16nts
)
6)bles 1 and 2.
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678ient #9) presented with a symptomatic pulmonary
mbolism 9 days after lead removal. Perfusion and
entilation scintigraphy showed a new defect, and
TE revealed the disappearance of the ghost.
None of the patients presented with a new
nfectious episode. Patient outcomes are summa-
ized in Table 4.
I S C U S S I O N
e present the incidence, predictors, and outcome
f the ghosts of permanent pacemaker and ICD
eads observed after device removal in a large
etrospective cohort. We showed that these ghosts
re significantly associated with the diagnosis of
DRIE and may be complicated by major cardio-
ascular events.
teristics of the 17 Patients With a Ghost
Removal
Indication
Major
Echocardiographic
Criteria*
Major
Microbiological
Criteria†
Number o
Minor
Criteria
CDRIE   3
LDI   1
CDRIE   3
CDRIE   3
CDRIE   2
LDI   3
le CDRIE   1
le CDRIE   1
CDRIE   3
CDRIE   2
le CDRIE   2
CDRIE   1
CDRIE   2
CDRIE   1
LDI   1
CDRIE   1
CDRIE   2
criteria deﬁned by lead or endocardial vegetation or endocardial abscess in con
m; RVT  right ventricle trabeculations; SVC  superior vena cava; TV  tricusp
teristics of the Patients Who Died
Removal
Indication
Pacemaker
Indication
Need for Permanent
Ventricular
Stimulation
Epicardial
Stimulation
CDRIE SAB  
LDI AVB  
CDRIE AVB  ck; SAB  sinoatrial block; other abbreviations as in Table 1.ncidence of ghosts. Ghost has not been considered
lead removal complication in the recent Heart
hythm Society Expert consensus endorsed by the
merican Heart Association (23). In our study,
hosts were present after lead removal in 8% of
atients and were observed only in patients with
evice infection. Two reasons may explain the
elatively high incidence of ghosts. First, our work
rovides one of the largest series of CDRIE with
ercutaneous lead removal. Furthermore, post–lead
emoval echocardiography was systematically per-
ormed during hospitalization, allowing identifica-
ion of this entity more frequently.
athophysiology. We found that CDRIE was the
ain factor associated with the appearance of
hosts. Thus, we can address the question of the
athogenesis of the ghosts. There is a lot of evi-
Lead
ulture
Time From
Implantation
(Median
Months) Localization
Ghost
Length
(mm)
Outcome at 3
Months
 29 SVC 25 Dead at day 90
 38 SVC 31 Alive
 172 SVC 40 Alive (surgery
at day 6)
 46 SVC 44 Alive
 49 SVC 78 Alive
 173 RVT 24 Alive
 8 RVT 50 Alive
 94 RVT 40 Alive
 16 SVC 30 Alive (PE at
day 3)
 0.7 SVC 50 Alive
 2 SVC 41 Alive
 54 SVC 80 Alive (surgery
at day 4)
 69 SVC 41 Alive
 99 RVT 41 Alive
 86 SVC 50 Alive
 41 TV 55 Alive
 22 TV 45 Dead at day 19
ith the lead. †Major bacteriologic criteria as deﬁned in the Methods section.
lve; other abbreviations as in Table 1.
diac Heart
Failure
Complication
of Extraction
Ghost
Length
(mm)
Days After Explantation,
Cause of Death
  25 90, sudden death
  31 391, cardiac failure
  45 19, sudden deathTable 4. Main Charac
Patient
Age
(yrs) Sex
f
C
1 85 Male
2 77 Male
3 40 Male
4 74 Male
5 46 Male
6 56 Male
7 87 Fema
8 82 Fema
9 67 Male
10 39 Male
11 58 Fema
12 71 Male
13 70 Male
14 79 Male
15 68 Male
16 73 Male
17 74 Male
*Major echocardiographic tact wTable 5. Main Charac
Patient
Age
(yrs) Sex
Car
1 85 Male
2 77 Male
17 74 Male
d
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679ence that permanent pacemaker and ICD leads are
urrounded by a fibrous sheath that grows with time
17–19). Stokes et al. (17) proposed a theory about
he mechanism of encapsulation of transvenous
ardiac pacemaker leads as a function of implant
ime based on the post-mortem examination of 101
ogs. Thrombosis due to endothelial damage and
lood flow perturbation occurs first. Then, throm-
us undergoes lysis or organization. This results in
he formation of collagenous tissue surrounding the
ead. Moreover, in other work, a histological anal-
sis showed that this fibrous sheath with sparse
nflammatory cells could be endothelialized and
ight have the rules of preventing migration of
ardiac device leads (19).
Incomplete removal of this fibrous sheath de-
ected by echocardiography was described in 2 case
eports of patients with device infection (20,21). In
ur series, we described 17 cases with incomplete
emoval of the sheath surrounding the leads. These
ndings suggest a possible role of infection in
he persisting fibrous sheath after lead extraction.
ome studies showed that infected leads are more
asily extracted than noninfected leads (24–26).
he infectious process, possibly breaking the seal
etween developed adhesions and the endocardial
urface, was suspected. However, in our study, we
id not find any association between an infectious
ndication and less use of sophisticated techniques
f removal such as laser sheath or snare. Otherwise,
ome studies found that at least 6 months are
eeded for fibrous tissue to encapsulate the leads
17). In our series, however, no association was
ound between the age of the leads and the appear-
nce of ghosts. Two patients who presented with
hosts had had lead removal 6 months after
mplantation. Moreover, our pathological findings
ere in agreement with the fact that ghosts are not
nly fibrous sheaths but possible vegetations. In
ummary, our proposed explanation is that ghosts
ight be infected fibrous sheaths mixed with veg-
tations that come off cardiac device leads because
f an infectious process.
host: a criterion for CDRIE? In 1994, Durack et al.
22) defined criteria for infective endocarditis using
pecific echocardiographic findings. Microorganism
solation and echocardiographic status were pro-
osed as major criteria in this classification. How-
ver, some authors showed that these criteria have a
oor sensitivity for diagnosing CDRIE (10,16).
his fact could be explained by the relatively low
ensitivity of echocardiography in detecting vegeta-
ion on pacemaker leads (10,11,16,27,28) and by grequently negative blood cultures in this setting
10,16).
Additional criteria have been proposed to increase
he sensitivity of Duke criteria, such as local symp-
oms, pulmonary embolism, and lead tip culture
10,16,29). Recently, Sohail et al. (16) proposed that
he presence of lead vegetation associated with clinical
vidence of generator pocket infection should classify
he patients as having definite CDRIE.
Our study showed that ghosts are strongly associ-
ted with a CDRIE diagnosis. However, if we applied
uke criteria in our series, 3 patients (Patients #6, #2,
nd #15) with ghosts met only the LDI definition.
hese 3 patients had positive lead cultures and local
igns of infection at the removal site. As a result, these
patients were considered as possibly having endo-
arditis. Considering ghosts as a major criterion of
DRIE, the appearance of a ghost combined with
DI signs would classify these 3 patients with LDI as
aving definite CDRIE. Thus, we propose that the
resence of ghosts may be included as a new criterion
n the diagnosis of CDRIE.
utcome. The prognostic value and therapeutic
mplications of the finding of a ghost are unknown.
n our series, all 17 patients were treated as having
DRIE, with a protocol including 6 weeks of
ntravenous antibiotic therapy associated with lead
xtraction. No cases of recurring infection were
dentified at the last follow-up visit. Two patients
ied during the 3-month follow-up. These 2 pa-
ients had no severe comorbidities. They had not
xperienced any complications from their lead re-
oval, and their infectious process was under con-
rol. This unexpected outcome might raise the
uestion of the involvement of a ghost in the
athophysiology of these deaths. Another patient
ied in the 12th month after lead removal. Al-
hough his ghost remained on the last TTE
erformed, he died of cardiac heart failure. More-
ver, 2 other patients required surgery as de-
cribed previously, and 1 patient had a symptom-
tic pulmonary embolism. Thus, the presence of a
host indicates the need for close clinical and
chocardiographic follow-up to detect complica-
ions. Surgery must be discussed in cases of
mbolisms and very large and mobile ghosts (21).
tudy limitations. This study has several limitations
ue to its retrospective nature. First, all patients did
ot undergo transesophageal echocardiography.
TE is known to have a relatively poor sensitivity
n detecting cardiac right-sided vegetation (30). In
ur series however, because of their large size,
hosts could be detected in 15 of the 17 patients by
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680TE. Another limitation was the time delay be-
ween the lead removal procedure and echocardi-
graphy. Echocardiography was performed during
he same hospitalization but after variable periods
fter lead removal. Consequently, some ghosts
ight have already embolized before echocardiog-
aphy was performed and may not be detected at
he time of echocardiographic examination. Finally,
epeat echocardiographic studies were not per-
ormed in patients without ghosts.
O N C L U S I O N S
ghost is a floating mass in the right cardiacmaker and defibrillator infections. In
Waldvogel FA, Bisno AL, editors. 1995;4:163–71.ead removal. The presence of a ghost seems to be
ssociated with the diagnosis of CDRIE and might
xplain sudden death in some patients after lead
xtraction. However, large prospective series of
nfected patients undergoing percutaneous lead re-
oval are needed to confirm these findings and to
efine the optimal management of this newly de-
cribed entity.
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